"Cholangiocarcinoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant tumor arising from the epithelium of the BILE DUCTS.
| Descriptor ID |
D018281
|
| MeSH Number(s) |
C04.557.470.200.025.450
|
| Concept/Terms |
Cholangiocarcinoma- Cholangiocarcinoma
- Cholangiocarcinomas
- Cholangiocellular Carcinoma
- Carcinoma, Cholangiocellular
- Carcinomas, Cholangiocellular
- Cholangiocellular Carcinomas
Extrahepatic Cholangiocarcinoma- Extrahepatic Cholangiocarcinoma
- Cholangiocarcinoma, Extrahepatic
- Cholangiocarcinomas, Extrahepatic
- Extrahepatic Cholangiocarcinomas
Intrahepatic Cholangiocarcinoma- Intrahepatic Cholangiocarcinoma
- Cholangiocarcinoma, Intrahepatic
- Cholangiocarcinomas, Intrahepatic
- Intrahepatic Cholangiocarcinomas
|
Below are MeSH descriptors whose meaning is more general than "Cholangiocarcinoma".
Below are MeSH descriptors whose meaning is more specific than "Cholangiocarcinoma".
This graph shows the total number of publications written about "Cholangiocarcinoma" by people in this website by year, and whether "Cholangiocarcinoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2004 | 2 | 0 | 2 |
| 2005 | 2 | 0 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 7 | 0 | 7 |
| 2008 | 1 | 1 | 2 |
| 2009 | 1 | 1 | 2 |
| 2010 | 1 | 1 | 2 |
| 2011 | 5 | 0 | 5 |
| 2012 | 4 | 1 | 5 |
| 2013 | 3 | 0 | 3 |
| 2014 | 2 | 0 | 2 |
| 2015 | 4 | 1 | 5 |
| 2016 | 2 | 0 | 2 |
| 2017 | 6 | 1 | 7 |
| 2018 | 3 | 1 | 4 |
| 2019 | 2 | 0 | 2 |
| 2020 | 5 | 2 | 7 |
| 2021 | 4 | 0 | 4 |
| 2022 | 8 | 0 | 8 |
| 2023 | 11 | 1 | 12 |
| 2024 | 3 | 1 | 4 |
| 2025 | 2 | 0 | 2 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cholangiocarcinoma" by people in Profiles.
-
Incidental Combined Hepatocellular-Cholangiocarcinoma in Liver Transplant Recipients: A Matched Cohort Study. Transpl Int. 2025; 38:15298.
-
Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response. NPJ Syst Biol Appl. 2025 Dec 12; 11(1):140.
-
Folliculin depletion results in liver cell damage and cholangiocarcinoma through MiT/TFE activation. Cell Death Differ. 2025 Aug; 32(8):1460-1472.
-
Burden of mortality from hepatocellular carcinoma and biliary tract cancers by race and ethnicity and sex in US, 2018-2023. Clin Mol Hepatol. 2024 Oct; 30(4):756-770.
-
An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202. ESMO Open. 2024 Jun; 9(6):103488.
-
Comprehensive Immunogenomic Profiling of IDH1-/2-Altered Cholangiocarcinoma. JCO Precis Oncol. 2024 Mar; 8:e2300544.
-
Revisiting the Malignant Masquerade at the Liver Hilum: Have We Made Progress? Ann Surg Oncol. 2024 May; 31(5):3062-3068.
-
Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with Cholangiocarcinoma. Cancer Epidemiol Biomarkers Prev. 2023 10 02; 32(10):1338-1347.
-
Great Debates: Neoadjuvant Therapy Should be Routinely Given for High-Risk Cholangiocarcinoma. Ann Surg Oncol. 2023 12; 30(13):7960-7965.
-
Mimickers of neuroendocrine tumors on endoscopic ultrasound-guided fine-needle aspirate material: Need for caution. Diagn Cytopathol. 2023 Nov; 51(11):E308-E313.